Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell Tolerance.
Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell Tolerance.
复制标题
新型重组轻症链球菌载体的口服给药可引发强大的疫苗抗原特异性口腔粘膜和全身抗体反应以及 T 细胞耐受性。
DOI：
10.1371/journal.pone.0143422
复制
发表时间：
2015
期刊：
影响因子：
3.7
通讯作者：
Cayabyab,MarkJ
中科院分区：
文献类型：
--
作者：
Xie,Emily;Kotha,Abhiroop;Biaco,Tracy;Sedani,Nikita;Zou,Jonathan;Stashenko,Phillip;Duncan,MargaretJ;Campos-Neto,Antonio;Cayabyab,MarkJ
